The product can not be sold in a country where it is illegal.

Buy 1cP-AL-LAD for sale online - USA vendor

Product Name: 1-Cyclopropionyl-6-allyl-6-nor-lysergic acid diethylamide
IUPAC Name: none
Other Names: (6aR,9R)1-Cyclopropionyl-N,N-diethyl-7-(prop-2-en-1-yl)-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide
Cas Number: none
Molecular Formula: none
Molar Mass: none g•mol-1
Effect: psychedelic, hallucinogen
Purity of the substance: 99.9%
Physical properties: liquid, blotters
Buy 1cP-AL-LAD for sale online - USA vendor
In Stock

- FREE shipping, 6-7 days delivery time
- Inner sending exist.
The main payment option is Bitcoin. As extra ways WU, MG.
We alwayse provide FREE samples of Top products with the main order.

Loyalty program exist, second order will be - 5%OFF

Safely work only with us! We provide - re-shipment guarantees.

Here you'll discover unused lawful items of immaculate quality.

Some time recently purchase if you don't mind make beyond any doubt that the items beneath your curiously are lawful in your country.

We do not offer a pharmaceutical items or beneath control items.

  1. Summary

    • Introduction to 1cP-AL-LAD
    • Emergence as a Research Chemical
    • User Reports and Cautionary Notes
  2. Chemistry

    • Structural Characteristics of 1cP-AL-LAD
    • Stereochemistry and Psychoactivity
  3. Pharmacology

    • Mechanism of Action
    • Relationship with AL-LAD
    • Comparative Potency and Effects
  4. Subjective Effects

    • Overview of Psychological and Physical Responses
    • Comparisons with AL-LAD and LSD
    • Potential Therapeutic Applications
  5. Physical Effects

    • Stimulation and Sensory Enhancements
    • Bodily Sensations and Physiological Changes
    • Risk Factors and Safety Considerations
  6. Visual Effects

    • Alterations in Perception and Visual Acuity
    • Distortions, Hallucinations, and Multi-sensory Experiences
  7. Hallucinatory States

    • Cognitive and Perceptual Phenomena
    • Time Distortion and Ego Dissolution
  8. Auditory Effects

    • Auditory Perception Alterations and Hallucinations
  9. Multi-sensory Effects

    • Synaesthetic Experiences and Transpersonal Insights
  10. Combination Effects

    • Interactions with Other Substances and Risk Assessment
  11. Toxicity and Harm Potential

    • Current Understanding of Health Risks and Long-term Effects
  12. Legal Status

    • Regulatory Landscape and Legal Considerations by Country


1-Cyclopropionyl-6-allyl-6-nor-lysergic acid diethylamide (1cP-AL-LAD), a novel psychedelic substance of the lysergamide class, is closely related to AL-LAD, potentially acting as a prodrug, though lacking substantial empirical evidence to confirm this hypothesis.

1cP-AL-LAD emerged as a research chemical, likely synthesized alongside other lysergamides such as 1cP-MiPLA, LSZ, and LST around 2020 or 2021, yet lacks significant validation for this claim.

User reports suggest similarities between the effects of 1cP-AL-LAD and AL-LAD, with slight variations. Despite its characterization as more recreational and less threatening than LSD, caution is strongly advised due to limited data on its pharmacological properties, metabolism, and toxicity.


1cP-AL-LAD, also known as 1-Cyclopropionyl-6-allyl-6-nor-lysergic acid diethylamide, is a semisynthetic alkaloid with a complex chemical structure. Unlike LSD, it lacks a methyl group at R6 but features an allyl group at R6 and a Cyclopropionyl substituent at R1, along with a N,N-diethylamide functional group.

Being a chiral compound with two stereocenters, 1cP-AL-LAD exhibits an absolute configuration of (5R, 8R), with other stereoisomers presumed to lack psychoactive properties.


1cP-AL-LAD likely acts as a partial agonist at 5-HT2A receptors, contributing to its psychedelic effects. It's also suspected to be a prodrug for AL-LAD, analogous to 1cP-LSD's relationship with LSD, though conclusive evidence is lacking.

With similarities to LSD in potency and mechanism, 1cP-AL-LAD offers a compressed duration and less intense effects, potentially making it more manageable for users.


Subjective Effects

While the subjective effects of 1cP-AL-LAD largely resemble those of AL-LAD or LSD, users commonly report shorter duration and reduced discomfort in physical side effects and anxiety. Some suggest it could be an effective introductory psychedelic alongside substances like 2C-B or 4-HO-MET.

Physical Effects

  • Stimulation: Similar to LSD, 1cP-AL-LAD primarily stimulates physical energy levels, contrasting with sedative effects of other psychedelics like psilocybin.
  • Spontaneous Bodily Sensations: Users experience euphoric tingling sensations, intensifying throughout the experience.
  • Perception of Bodily Lightness: Often accompanies stimulation effects.
  • Physical Euphoria: Occurs inconsistently and may manifest as discomfort.
  • Changes in Felt Bodily Form: Users may feel connected to objects or experience unity sensations.
  • Tactile Enhancement: Heightened tactile sensations are consistent.
  • Temperature Regulation Suppression: Users may experience changes in body temperature, necessitating caution.
  • Nausea: Mild nausea can occur, typically during peak effects.
  • Stamina Enhancement: Mild compared to traditional stimulants.
  • Bodily Control Enhancement: Users may feel enhanced control over bodily movements.
  • Appetite Suppression
  • Difficulty Urinating
  • Increased Blood Pressure
  • Increased Heart Rate
  • Increased Perspiration
  • Muscle Contractions and Spasms
  • Increased Libido
  • Excessive Yawning
  • Pupil Dilation
  • Increased Salivation
  • Seizure: Risk may be increased, particularly in predisposed individuals under taxing conditions.

Visual Effects

  • Enhancements: Visual acuity, color, and pattern recognition are heightened.
  • Distortions: Drifting, tracers, after-images, and color shifting are common.
  • Geometry: Intricate, brightly lit, and colorful geometric patterns, similar to LSD or 2C-B.

Hallucinatory States

  • Machinescapes and Transformations
  • Internal Hallucinations: Consistent in dark environments at higher doses.
  • Cognitive Effects: Enhanced analysis, conceptual thinking, and cognitive euphoria.
  • Time Distortion and Thought Acceleration
  • Ego Death and Memory Suppression
  • Deja Vu and Thought Loops

Auditory Effects

  • Auditory Distortion and Enhancement
  • Auditory Hallucinations

Multi-sensory Effects

  • Synaesthesia: Rare and non-reproducible in its fullest manifestation.

Transpersonal Effects

  • Existential Self-Realization and Unity Perception
  • Perception of Eternalism and Interconnectedness

Combination Effects

  • Alcohol: May reduce anxiety but can exacerbate physical side effects.
  • Benzodiazepines: Suppress effects of 1cP-AL-LAD.
  • Cannabis: Intensifies effects but increases risk of negative psychological reactions.
  • Dissociatives: Enhance hallucinatory effects but increase risk of confusion.
  • MDMA: Highly synergistic, enhances physical and cognitive effects, but caution advised due to potential neurotoxicity.

    Toxicity and Harm Potential

    The toxicity and long-term health effects of recreational 1cP-AL-LAD use remain largely unstudied in scientific contexts, and the exact toxic dose is unknown due to its status as a research chemical with minimal human usage history.

    Health Effects

    Anecdotal reports suggest minimal negative health effects at low to moderate doses of 1cP-AL-LAD used sparingly. However, caution should be exercised, and independent research is necessary before combining it with other substances.

    Physical Side Effects

    Similar to LSD, acute exposure to 1cP-AL-LAD appears to be associated with relatively few physical side effects. It's likely non-addictive with low toxicity relative to dose, although formal studies are lacking.

    Mental Health Risks

    As with LSD and other psychedelics, 1cP-AL-LAD may potentially trigger adverse reactions in individuals with underlying psychiatric conditions. People with personal or family histories of mental illness are advised against its use, especially without medical supervision.

    Tolerance and Addiction Potential

    1cP-AL-LAD is presumed to be non-habit-forming, with diminishing desire for use over time, similar to LSD. Tolerance develops rapidly, with effects diminishing after ingestion and taking about 5-7 days to reduce by half, presenting cross-tolerance with other psychedelics.


    The LD50 of 1cP-AL-LAD is unknown, and adverse psychological reactions, such as anxiety and panic attacks, are common at higher doses. Severe adverse effects may require medical attention, and administration of benzodiazepines or antipsychotics can help alleviate cognitive distress.

    Legal Status

    1cP-AL-LAD exists in a legal gray area in many countries. While not explicitly illegal in most jurisdictions, possession under certain circumstances, such as intent to sell or consume, may lead to legal repercussions. Specific laws vary by country, with examples including:

    • Austria: Subject to regulation under analog laws.
    • Germany: Illegal as of July 2021.
    • Switzerland: Considered a controlled substance under certain conditions.
    • United States: Potentially illegal under the Federal Analogue Act due to its relation to LSD.


Cyclopropionyl-6-allyl-6-nor-lysergic acid diethylamide (1cP-AL-LAD) stands as a promising yet enigmatic member of the lysergamide family, closely linked to AL-LAD but with distinctive characteristics. While user reports suggest its recreational potential and milder effects compared to LSD, its pharmacological profile remains poorly understood, warranting caution and further research. The compound's legal status adds another layer of complexity to its usage and availability, emphasizing the need for responsible exploration and regulatory clarity in the psychedelic landscape.


1. What is 1cP-AL-LAD?

  • 1cP-AL-LAD, short for Cyclopropionyl-6-allyl-6-nor-lysergic acid diethylamide, is a novel psychedelic compound belonging to the lysergamide class. It is structurally similar to AL-LAD but features a cyclopropionyl group at R1 instead of a methyl group.

2. How does 1cP-AL-LAD compare to other psychedelics like LSD?

  • While 1cP-AL-LAD shares similarities with LSD and AL-LAD in its psychedelic effects, users often report a shorter duration and milder overall experience compared to LSD. However, caution is advised due to limited research on its pharmacological properties and potential risks.

3. Is 1cP-AL-LAD legal?

  • The legal status of 1cP-AL-LAD varies by country. In some jurisdictions, it may fall into a legal gray area, while in others, it may be explicitly regulated or prohibited. It's essential to research and understand the specific laws and regulations in your region before obtaining or using 1cP-AL-LAD.

4. What are the potential risks associated with 1cP-AL-LAD use?

  • Like other psychedelics, 1cP-AL-LAD carries potential risks, including psychological distress, adverse reactions, and, in rare cases, triggering underlying mental health conditions. Additionally, the long-term health effects and toxicity of 1cP-AL-LAD remain largely unstudied, emphasizing the importance of responsible use and risk awareness.

5. How should 1cP-AL-LAD be consumed?

  • 1cP-AL-LAD is typically ingested orally, often in the form of blotter paper or liquid solutions. Dosage recommendations vary, but it's crucial to start with a low dose and gradually titrate upwards to assess individual sensitivity and tolerance. Additionally, setting and mindset play significant roles in shaping the psychedelic experience, so creating a safe and comfortable environment is essential.

6. Can 1cP-AL-LAD be used therapeutically?

  • While there is anecdotal evidence suggesting potential therapeutic benefits of psychedelic substances, including 1cP-AL-LAD, formal clinical research is needed to validate these claims. Some users report insights, emotional processing, and personal growth experiences with psychedelics, but self-medication without professional guidance carries inherent risks.

7. Are there any known drug interactions with 1cP-AL-LAD?

  • Like with any psychoactive substance, combining 1cP-AL-LAD with other drugs, including prescription medications and recreational substances, can potentially lead to unpredictable effects and increased risk of adverse reactions. It's essential to consult a healthcare professional or pharmacist before combining 1cP-AL-LAD with other substances.

8. How does tolerance to 1cP-AL-LAD develop?

  • Tolerance to 1cP-AL-LAD builds rapidly with repeated use, leading to diminished effects over time. Cross-tolerance may also occur with other psychedelics. To mitigate tolerance, it's recommended to space out usage and avoid frequent or excessive consumption.

9. What should I do in case of a challenging or difficult psychedelic experience with 1cP-AL-LAD?

  • If you or someone you know is experiencing distress during a 1cP-AL-LAD session, it's crucial to prioritize safety and provide a supportive environment. Techniques such as deep breathing, grounding exercises, and engaging in calming activities like listening to music or going for a walk can help alleviate discomfort. If necessary, seek assistance from a trusted friend or professional to ensure physical and emotional well-being.

10. Where can I find more information about 1cP-AL-LAD?

  • While resources such as online forums, research articles, and harm reduction organizations may provide valuable insights, it's essential to critically evaluate information and prioritize reputable sources. Additionally, engaging in open and honest discussions with experienced individuals and healthcare professionals can help deepen understanding and promote safe and informed decision-making regarding 1cP-AL-LAD use.

1kg $1590

500g $1390

500g $1080

out of stock

100g $390

100g $550

1kg $1590

100g $390

1kg $1590

1kg $1590

1kg $1590